T

takeair

lightning_bolt Market Research

TakeAir Company Profile



Background



Overview

TakeAir, founded in 2016 by Marie-Paule Coryn and Jo Pannecoucke, is a biotechnology company headquartered in Ghent, Belgium. The company specializes in enhancing indoor air quality through innovative biospheric air treatment solutions. By integrating beneficial microorganisms into existing ventilation systems, TakeAir aims to create healthier indoor environments and reduce energy consumption.

Mission and Vision

TakeAir's mission is to provide revolutionary biotechnology that fosters a balanced microbial climate, safeguarding indoor spaces from airborne pathogens. Their vision is to excel in microbial biotechnology for the built environment, ensuring all building occupants benefit from healthy air, even in polluted urban settings. This approach enhances occupant well-being, decreases energy usage, and adds value for real estate owners.

Key Strategic Focus



Core Objectives

TakeAir focuses on improving indoor air quality by introducing beneficial microorganisms into ventilation systems, aiming to:

  • Enhance occupant health and well-being.

  • Reduce energy consumption.

  • Increase property value for real estate owners.


Areas of Specialization

The company specializes in:

  • Biospheric Air Treatment.

  • Indoor air quality audits.

  • Issuing certificates based on the Biospheric Index.


Key Technologies Utilized

TakeAir employs:

  • Automated biotechnology systems.

  • Sensor technology integrated with ventilation systems.

  • Sea-Aeration process using carrageenan extract.

  • BioRemediation with Ammonia Oxidizing Bacteria (AOB).


Primary Markets Targeted

The company primarily serves:

  • Commercial real estate sector.

  • Building management companies.

  • Urban environments with high pollution levels.


Financials and Funding



Funding History

TakeAir has received non-equity assistance from AcceliCITY powered by Leading Cities, indicating support for its innovative approach to indoor air quality.

Intended Utilization of Capital

The capital is likely allocated towards:

  • Research and development of new technologies.

  • Expansion of market reach.

  • Enhancing operational capabilities.


Pipeline Development



Key Pipeline Candidates

TakeAir's primary offering is the Biospheric Air Treatment system, which is continually refined to:

  • Integrate seamlessly with existing HVAC systems.

  • Enhance efficiency in pathogen elimination.

  • Reduce energy consumption.


Stages of Development

The technology is in the implementation stage, with successful deployments in various commercial buildings.

Target Conditions

The system targets:

  • Airborne pathogens.

  • Indoor pollutants.

  • Energy inefficiencies in ventilation systems.


Anticipated Milestones

Future milestones include:

  • Expanding the client base.

  • Achieving higher energy savings.

  • Obtaining additional certifications for air quality standards.


Technological Platform and Innovation



Proprietary Technologies

TakeAir's proprietary technologies include:

  • Sea-Aeration process using carrageenan extract.

  • BioRemediation with Ammonia Oxidizing Bacteria (AOB).


Significant Scientific Methods

The company employs:

  • Biological air purification methods.

  • Integration of biotechnology with HVAC systems.


Leadership Team



Key Executives

  • Jo Pannecoucke: Co-founder and CEO.

  • Marie-Paule Coryn: Co-founder and Account Manager.


Professional Backgrounds

  • Jo Pannecoucke: Experienced in biotechnology and business development, leading TakeAir's strategic direction.

  • Marie-Paule Coryn: Specializes in client relations and operational management, ensuring effective service delivery.


Key Contributions

  • Jo Pannecoucke has been instrumental in developing and implementing the Biospheric Air Treatment system.

  • Marie-Paule Coryn has established strong partnerships with commercial real estate clients, facilitating the adoption of TakeAir's solutions.


Market and Competitor Analysis



Market Insights and Dynamics

The indoor air quality improvement market is growing, driven by increasing awareness of health impacts and energy efficiency. Companies are focusing on innovative solutions to address these concerns.

Competitor Analysis

Key competitors include:

  • Rensair: Offers air purification and HVAC optimization solutions.

  • Breezo: Provides probiotic environmental treatments for indoor air quality.

  • Zentox: Develops air purification technology using photocatalytic oxidation.


Strategic Collaborations and Partnerships

TakeAir has collaborated with:

  • CBRE Investment Management: To implement air treatment solutions in commercial properties.

  • Vattenfall: For integrating energy-efficient air purification systems.

  • Vinçotte: For certification and quality assurance services.

Browse SuperAGI Directories
agi_contact_icon
People Search
agi_company_icon
Company Search
AGI Platform For Work Accelerate business growth, improve customer experience & dramatically increase productivity with Agentic AI